Envoy Medical (COCHW) Net Margin (2022 - 2026)

Envoy Medical has disclosed Net Margin across 5 years of filings, most recently posting 14617.95% for Q1 2026.

• Net Margin for Q1 2026 came in at 14617.95%, down 106143.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 12020.09% (up 51482.0% YoY), and the FY2025 annual result was 11892.95%, up 53950.0% from the prior year.
• Net Margin came in at 14617.95% for Q1 2026 at Envoy Medical, down from 10316.0% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 1750.0% in Q3 2023 to a low of 57385.0% in Q4 2022.
• The 5-year median for Net Margin is 13107.14% (2024), against an average of 14704.56%.
• Across the five-year window, Net Margin surged 5081237 bps in 2023 and plunged 1485714 bps in 2024, its largest moves.
• Envoy Medical's Net Margin stood at 57385.0% in 2022, then jumped by 89 bps to 6572.63% in 2023, then plunged by 178 bps to 18300.0% in 2024, then surged by 44 bps to 10316.0% in 2025, then tumbled by 42 bps to 14617.95% in 2026.
• The last three Net Margin figures came in at 14617.95% (Q1 2026), 10316.0% (Q4 2025), and 18445.24% (Q3 2025), per Business Quant data.